Is Crestchem overvalued or undervalued?

As of 14 November 2025, Crestchem's valuation grade has moved from very attractive to attractive, indicating a shift in market perception. The company is currently assessed as undervalued, given its price-to-earnings (PE) ratio of 17.82, a price-to-book value of 4.46, and an EV to EBITDA ratio of 15.74. These ratios suggest that Crestchem is trading at a reasonable valuation compared to its peers.
In comparison to its industry, Crestchem's PE ratio is significantly lower than that of Solar Industries at 95.17 and Gujarat Fluoroch at 57.32, both categorized as very expensive. Additionally, Godrej Industries, which is also rated attractive, has a PE ratio of 37.36, further reinforcing Crestchem's relative undervaluation. Despite recent stock performance trailing the Sensex, particularly with a year-to-date decline of 57.15% compared to the Sensex's gain of 8.22%, the underlying financial metrics suggest that Crestchem remains a compelling investment opportunity in the specialty chemicals sector.